Account
The Mavericks wins communications mandate for Stellaris Venture Partners
Mumbai: Marketing communications advisory The Mavericks India has been awarded the integrated communications mandate for early-stage fund Stellaris Venture Partners.
“We are thrilled to partner Stellaris Venture Partners in co-creating its communications approach and amplifying its business impact amongst relevant stakeholders,” stated The Mavericks founder and CEO Chetan Mahajan. “The fund is a formidable force in the Indian venture capital ecosystem that discovered soonicorns such as Whatfix and Mamaearth, and continues to identify and invest in potential movers and shakers.”
As one of the top early-stage tech-focused funds in the country, Stellaris recently announced the launch of its second fund of $225 million. The fund has backed many market movers including Whatfix, Mamaearth, Slintel (recently acquired by US-based unicorn 6Sense), mFine, and Propelld to name a few.
“As the ecosystem has grown, so has the number of funds, and the need for every fund to clearly articulate its purpose, positioning, and differentiation,” said Stellaris Venture Partners – partner Alok Goyal. “We are confident that their expertise will help us in communicating our positioning of an early-stage fund that partners with bold founders at nascent stages of their ventures to help transform ideas into resilient businesses.”
MUMBAI: BigTrunk Communications, an integrated digital marketing agency known for driving brand transformations across industries, has been awarded the digital marketing mandate for Soframycin, one of India’s most trusted antiseptic cream brands from the EncubeEthicals portfolio. With this collaboration, Soframycin makes its debut into the digital space, aiming to amplify its presence across India through compelling social media narratives and data-led campaigns. BigTrunk will lead the brand’s digital strategy and execution, with a focus on connecting Soframycin’s legacy of trust with today’s health-conscious and digitally engaged audience.
Soframycin has been a household name for generations, widely recognized for its efficacy in treating cuts, burns, and wounds. Backed by the scientific rigor and pharmaceutical expertise of EncubeEthicals, a pharmaceutical powerhouse since 1998, the brand benefits from the expertise of over 1,400 professionals, including more than 200 R&D specialists and a robust team of quality experts. With a presence in over 50 countries, Encube’s commitment to excellence in topical formulations adds deep credibility to Soframycin’s legacy. Now, as the brand enters the digital space, BigTrunk Communications will lead the charge in reimagining Soframycin’s story—creating modern, relatable digital experiences that stay true to its heritage.
“As we take Soframycin into its next chapter of growth, embracing digital media is not just a strategy but a necessity. We wanted a partner who could translate our scientific credibility into engaging, relatable content for today’s audience,” said Soframycin vice president – marketing, Ajay Rawal. “BigTrunk’s deep understanding of healthcare communications and digital behavior makes them the ideal partner to build meaningful narratives around wound care, trust, and wellbeing.”
“Soframycin is more than a product—it’s a legacy deeply rooted in care and science,” added BigTrunk Communications founder & managing director Bharat Subramaniam. “We’re excited to take on this responsibility of guiding a heritage brand into the digital world. Our focus will be on creating contextual storytelling and purpose-driven campaigns that bring Soframycin closer to Indian families, both old and new.”
